Literature DB >> 8395513

Identification of phosphorylation sites in the recombinant catalytic subunit of cAMP-dependent protein kinase.

W Yonemoto1, S M Garrod, S M Bell, S S Taylor.   

Abstract

The catalytic subunit of cAMP-dependent protein kinase expressed in Escherichia coli is a phosphoprotein. By in vivo labeling with [32Pi]orthophosphate, the sites of phosphorylation were identified as Ser-10, Ser-139, Thr-197, and Ser-338. Two of these sites, Thr-197 and Ser-338, are found in the mammalian enzyme (Shoji, S., Titani, K., Demaille, J. G., and Fischer, E. H. (1979) J. Biol. Chem. 254, 6211-6214). The predominant isoform is phosphorylated at Ser-10, Ser-338, and Thr-197. The isoforms cannot be readily interconverted by in vitro autophosphorylation, suggesting that the phosphates are relatively stable once the mature protein is assembled. Unlike the mammalian enzyme, the recombinant enzyme is not myristylated at its animo terminus. By coexpressing the catalytic subunit and N-myristyl transferase, the recombinant catalytic subunit is myristylated, and, under these conditions, phosphorylation at Ser-10 is reduced. The fact that recombinant catalytic subunit mutants that are enzymatically impaired are not phosphorylated in vivo indicates that the phosphorylation of the catalytic subunit observed in E. coli is due to autophosphorylation. Whether this process is intramolecular or intermolecular cannot be distinguished. Although autophosphorylation accounts for the modification of the catalytic subunit when it is expressed in E. coli, there may be heterologous protein kinases that are responsible for its in vivo phosphorylation when the enzyme is expressed in eukaryotic cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8395513

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Cotranslational cis-phosphorylation of the COOH-terminal tail is a key priming step in the maturation of cAMP-dependent protein kinase.

Authors:  Malik M Keshwani; Christian Klammt; Sventja von Daake; Yuliang Ma; Alexandr P Kornev; Senyon Choe; Paul A Insel; Susan S Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-09       Impact factor: 11.205

2.  An Isoform-Specific Myristylation Switch Targets Type II PKA Holoenzymes to Membranes.

Authors:  Ping Zhang; Feng Ye; Adam C Bastidas; Alexandr P Kornev; Jian Wu; Mark H Ginsberg; Susan S Taylor
Journal:  Structure       Date:  2015-08-13       Impact factor: 5.006

3.  A-kinase-interacting protein localizes protein kinase A in the nucleus.

Authors:  Mira Sastri; David M Barraclough; Peter T Carmichael; Susan S Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-03       Impact factor: 11.205

4.  In vivo activation of protein kinase A in Schizosaccharomyces pombe requires threonine phosphorylation at its activation loop and is dependent on PDK1.

Authors:  Yi Tang; Maureen McLeod
Journal:  Genetics       Date:  2004-12       Impact factor: 4.562

5.  Phosphorylation and activation of cAMP-dependent protein kinase by phosphoinositide-dependent protein kinase.

Authors:  X Cheng; Y Ma; M Moore; B A Hemmings; S S Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

6.  Physiological phosphorylation of protein kinase A at Thr-197 is by a protein kinase A kinase.

Authors:  R D Cauthron; K B Carter; S Liauw; R A Steinberg
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

7.  Aurora-A site specificity: a study with synthetic peptide substrates.

Authors:  Stefano Ferrari; Oriano Marin; Mario A Pagano; Flavio Meggio; Daniel Hess; Mahmoud El-Shemerly; Agnieszka Krystyniak; Lorenzo A Pinna
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

8.  Direct modulation of the protein kinase A catalytic subunit α by growth factor receptor tyrosine kinases.

Authors:  George B Caldwell; Alan K Howe; Christian K Nickl; Wolfgang R Dostmann; Bryan A Ballif; Paula B Deming
Journal:  J Cell Biochem       Date:  2012-01       Impact factor: 4.429

9.  Repeated Mu-Opioid Exposure Induces a Novel Form of the Hyperalgesic Priming Model for Transition to Chronic Pain.

Authors:  Dioneia Araldi; Luiz F Ferrari; Jon D Levine
Journal:  J Neurosci       Date:  2015-09-09       Impact factor: 6.167

10.  The soluble guanylate cyclase stimulator BAY 41-2272 inhibits vascular smooth muscle growth through the cAMP-dependent protein kinase and cGMP-dependent protein kinase pathways.

Authors:  Chintamani N Joshi; Danielle N Martin; Jonathan C Fox; Natalia N Mendelev; Trisha A Brown; David A Tulis
Journal:  J Pharmacol Exp Ther       Date:  2011-08-08       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.